Skip to main content
    K

    Kairos Pharma, Ltd. (KAPA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $0.41
    -0.04 (-8.82%)

    Market Cap: $1.54M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Kairos Pharma, Ltd. (KAPA) Earnings: Report Dates and Results

    Updated Nov 13, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    In the quarter ended Sep 30, 2026, Kairos Pharma reported EPS of -$0.59, above the -$0.63 estimate. It beat the EPS estimate in 2 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    22%(2/9)
    Avg Surprise
    -107.55%
    Streak
    2 Q

    Upcoming Estimates

    Report date not yet scheduledPeriod ending Dec 31, 2026
    EPS Consensus-$0.64
    Range-$0.75 - -$0.51
    4 analysts
    Revenue Consensus
    N/A
    RangeN/A
    4 analysts

    Next Report

    KAPA's report for the quarter ending Dec 31, 2026 is not on the earnings calendar yet.

    Earnings History

    Of the 9 quarters below that had an estimate, KAPA beat 2, missed 6 and matched 1. The widest gap in the table came in the quarter ended Sep 30, 2024, when EPS landed 400.00% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$0.59-$0.63-$0.63 - -$0.63+6.35%BeatN/A10 up, 0 downNov 13, 2026
    Jun 30, 2026-$0.06-$0.09-$0.09 - -$0.09+33.33%BeatN/A10 up, 0 downAug 12, 2026
    Mar 31, 2026-$0.56-$0.49-$0.49 - -$0.49-14.29%MissN/A10 up, 0 downMay 13, 2026
    Dec 31, 2025-$0.07$0.03$0.03 - $0.03-333.33%MissN/A10 up, 0 downMar 31, 2026
    Sep 30, 2025-$0.07-$0.07-$0.10 - -$0.050.00%In lineN/A20 up, 0 downNov 14, 2025
    Jun 30, 2025-$0.08-$0.05-$0.05 - -$0.05-60.00%MissN/A10 up, 0 downAug 12, 2025
    Mar 31, 2025-$0.03-$0.02N/A-50.00%MissN/AN/AN/AApr 15, 2025
    Dec 31, 2024-$0.05-$0.02-$0.02 - -$0.02-150.00%MissN/A10 up, 0 downFeb 26, 2025
    Sep 30, 2024-$0.10-$0.02N/A-400.00%MissN/AN/AN/ANov 14, 2024
    Jun 30, 2024-$0.02N/AN/AN/AN/AN/AN/AN/AAug 28, 2024
    Last 10 quarters

    Annual EPS

    Fiscal year endedEPSChange
    Sep 30, 2026-$1.21N/A
    Jun 30, 2026-$0.62N/A
    Dec 31, 2025-$0.25N/A
    Jun 30, 2025-$0.16N/A
    Dec 31, 2024-$0.17N/A

    Frequently Asked Questions About KAPA

    Did KAPA beat earnings estimates last quarter?

    Yes. Kairos Pharma reported EPS of -$0.59 for the quarter ended Sep 30, 2026, above the -$0.63 estimate, a 6.35% surprise.

    What EPS do analysts expect from KAPA next quarter?

    The consensus EPS estimate for Kairos Pharma for the quarter ending Dec 31, 2026 is -$0.64 from 4 analysts, with estimates from -$0.75 to -$0.51.

    How often does KAPA beat earnings estimates?

    Kairos Pharma beat the EPS estimate in 2 of the last 8 quarters, with an average surprise of -70.99%.